McKesson Corp (MCK): Cost of Revenue

Annual figures by period end, from SEC filings.

$388.88B
Year ended 2026-03-31
$396.03B
Trailing 12 months to 2026-06-30
+13.7%
3-year compound annual growth
+11.5%
5-year compound annual growth
+8.0%
10-year compound annual growth
2008-03-31: $96.69B2009-03-31: $101.25B2010-03-31: $103.03B2011-03-31: $106.11B2012-03-31: $115.92B2013-03-31: $115.31B2014-03-31: $129.04B2015-03-31: $167.63B2016-03-31: $179.47B2017-03-31: $187.26B2018-03-31: $197.17B2019-03-31: $202.56B2020-03-31: $219.03B2021-03-31: $226.08B2022-03-31: $250.84B2023-03-31: $264.35B2024-03-31: $296.12B2025-03-31: $345.73B2026-03-31: $388.88B$388.88B
2008-03-31 Cost of Revenue (USD) 2026-03-31
Period endedCost of RevenueChange YoYSource filing
2026-03-31$388.88B+12.5%2026-05-08, From 2025-04-01
2025-03-31$345.73B+16.8%2026-05-08, From 2024-04-01
2024-03-31$296.12B+12.0%2026-05-08, From 2023-04-01
2023-03-31$264.35B+5.4%2025-05-09, From 2022-04-01
2022-03-31$250.84B+11.0%2024-05-08, From 2021-04-01
2021-03-31$226.08B+3.2%2023-05-09, From 2020-04-01
2020-03-31$219.03B+8.1%2022-05-09, From 2019-04-01
2019-03-31$202.56B+2.7%2021-05-12, From 2018-04-01
2018-03-31$197.17B+5.3%2020-05-22, From 2017-04-01
2017-03-31$187.26B+4.3%2019-05-15, From 2016-04-01
2016-03-31$179.47B+7.1%2018-05-24, From 2015-04-01
2015-03-31$167.63B+29.9%2017-05-22, From 2014-04-01
2014-03-31$129.04B+11.9%2016-05-05, From 2013-04-01
2013-03-31$115.31B-0.5%2015-05-12, From 2012-04-01
2012-03-31$115.92B+9.2%2014-05-14, From 2011-04-01
2011-03-31$106.11B+3.0%2013-05-07, From 2010-04-01
2010-03-31$103.03B+1.8%2012-05-02, From 2009-04-01
2009-03-31$101.25B+4.7%2011-05-05, From 2008-04-01
2008-03-31$96.69Bn/a2010-05-04, From 2007-04-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
McKesson Corp (MCK)2026-03-31$388.88B+12.5%
Cencora, Inc. (COR)2025-09-30$309.85B+9.1%
Cardinal Health Inc (CAH)2026-06-30$244.47B+14.0%
Herbalife Ltd. (HLF)2025-12-31$1.11B+0.9%
Nu Skin Enterprises, Inc. (NUS)2025-12-31$453.76M-17.5%
Cosmos Health Inc. (COSM)2025-12-31$57.38M+14.5%
DataMeds AI, Inc. (MEDS)2025-12-31$29.76M+81.9%
Stemtech Corp (STEK)2025-12-31$566.9K-57.3%
HWH International Inc. (ESYN)2025-12-31$407.2K-37.5%

Compare MCK, COR, CAH, HLF side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗